Abstract Details

Title Preliminary Evidence for Improved Efficacy When Patients Treat with Sumatriptan Formulated with RT Tehcnology[trade] during Migraine with Visual Aura

Topic Headache and Pain

Presentation(s) (-)

Poster/Presentation
Number 003

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Erin E. Flynn	No disclosure on file
Aad Verrips, MD, PhD (Canisius-Wilhelmina Hospital)	No disclosure on file
Himanshu Suri, MD (Medstar Georgetown University Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jessica Stevens, MD (FDA)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Ralf Linker (Uniklinik Erlangen)	Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.